The primary aim of this study was to explore the safety profile of biologic treatments in Behçet's disease (BD), based on their mechanism of action; the secondary aim was to study any potential variation in terms of retention rate according to each single drug.

Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study / Cantarini, L., Talarico, R., Generali, E., Emmi, G., Lopalco, G., Costa, L., Silvestri, E., Caso, F., Franceschini, R., Cimaz, R., Iannone, F., Galeazzi, M., Selmi, C.. - In: INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. - ISSN 1756-185X. - STAMPA. - 20:(2017), pp. 103-108. [10.1111/1756-185X.12732]

Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study

EMMI, GIACOMO;
2017-01-01

Abstract

The primary aim of this study was to explore the safety profile of biologic treatments in Behçet's disease (BD), based on their mechanism of action; the secondary aim was to study any potential variation in terms of retention rate according to each single drug.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/3073487
 Avviso

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 19
social impact